Glycemic control has not been impacted by pandemic

8 Jul
2021

Glycemic control has not been impacted by pandemic

By Staff Writer

(HealthDay)—While diabetes-related outpatient visits and testing fell during the pandemic, there was no negative association with medication fills or glycemic control among U.S. adults with diabetes, according to a research letter published online July 6 in JAMA Internal Medicine.

Sadiq Y. Patel, Ph.D., from Harvard University in Boston, and colleagues used deidentified claims from OptumLabs Data Warehouse to identify adults with type 2 diabetes and continuous enrollment in commercial or Medicare Advantage health plans for 2019 (1,357,029 individuals) and 2020 (1,364,522 individuals).

The researchers found that across the entire pandemic period, adjusted use was lower in 2020 versus 2019 for outpatient visits (relative percent change, −2.6 percent), hemoglobin A1c testing (−6.5 percent), retinopathy testing (−18.8 percent), and nephropathy testing (−8.5 percent). However, medication fill rates were similar for the two time periods and levels of hemoglobin A1c were nearly identical for the two time periods.

"Mail-order pharmacies and pharmacy delivery services may have been key during the pandemic in ensuring patients receive their medications," the authors write. "Together, these would be consistent with diabetes disaster preparedness guidelines, which emphasize prioritizing access to medications over access to health care professionals during an emergency."

Disclaimer:- As every caution has been taken to provide our readers with the most accurate information and honest analysis. Please check the pros and cons of the same before making any decision on the basis of the shared details.

Subscribe to our Newsletter from the main page & You will get all news in your Inbox.